Skip to content

Stanford Medicine Scientists have devised a blood test to predict some cancer relapses after patients have already been treated.

Stanford Medicine Scientists have devised a blood test to predict some cancer relapses after patients have already been treated.

Published on

'Resting' exhausted cancer-fighting immune cells enhances their tumor-killing activity, which may help people with blood and solid cancers.

'Resting' exhausted cancer-fighting immune cells enhances their tumor-killing activity, which may help people with blood and solid cancers.

In this In the Spotlight, hematologist/oncologist Gabriel Mannis talks about his passion for medicine and his experience working at Sesame Street.

In this In the Spotlight, hematologist/oncologist Gabriel Mannis talks about his passion for medicine and his experience working at Sesame Street.

Stanford scientists have moved a big step closer toward using engineered immune cells to treat many forms of pediatric cancer.

Stanford scientists have moved a big step closer toward using engineered immune cells to treat many forms of pediatric cancer.

Published on

A new technique gives doctors an early view of which pediatric leukemia patients will relapse, and may point the way toward better cancer drugs.

A new technique gives doctors an early view of which pediatric leukemia patients will relapse, and may point the way toward better cancer drugs.

Published on

The question sounds more like sociology than biology: What would happen if you could take a cell gone bad -- a cancer cell -- bring …